hrs4r
Quiero donar
Firma
RAFEL MARCOS-GRAGERA
Posición
Cap de Grup - R4
Jefe de Grupo - R4

Projectes

Codi oficial: Projecte IJC - Dr. Rafael Marcos-Gragera Data inicio:01/01/2021 Data fi: 31/12/2024 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: FUNDACIÓ INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS Ajuda: 12,500 €
Codi oficial: 6822ZB3KJ Data inicio:01/01/2023 Data fi: 31/12/2024 Investigador/a principal: DAVID GALLARDO GIRALT Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 0 €

Publicacions

0

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)

Neuro-Oncology, 2023, 25, 580-592 dx.doi.org/10.1093/neuonc/noac217

Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20010405

Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, Arndt V, Francisci S, Dochez C, Ribes J, Fernández LP, Gavin A, Gatta G, Marcos-Gragera R, Lievens Y, Allemani C, De Angelis R, Visser O, Van Eycken L

Cancer treatment data available in European cancer registries: Where are we and where are we going?

Frontiers in oncology, 2023, 13, 1109978-1109978 dx.doi.org/10.3389/fonc.2023.1109978
0

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms24098005
0

A Global Perspective on the Controversy of Gleason Score 6 Prostate Cancer Reporting: The Potential Role of Population-Based Cancer Registries.

Jco Global Oncology, 2023, 9 dx.doi.org/10.1200/GO.22.00427

Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X

Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening

EUROPEAN RADIOLOGY, 2022, 32, 621-629 dx.doi.org/10.1007/s00330-021-08118-y

Sanvisens A, Ameijide A, Carulla M, Marcos-Gragera R

Estimates of the incidence of hematological neoplasms in Spain, 2021: Study of the Spanish Network of Cancer Registries (REDECAN)

MEDICINA CLINICA, 2022, 158, 284-290 dx.doi.org/10.1016/j.medcli.2021.09.035

Solans M, Sanvisens A, Ameijide A, Merino S, Rojas D, Alemán A, Banqueri E, Chico M, Marcos AI, de Castro V, Gil L, de Munain AL, Puigdemont M, Sánchez MJ, Perucha J, Ruiz-Armengol P, Chirlaque MD, Guevara M, Carulla M, Marcos-Gragera R

Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries

SCIENTIFIC REPORTS, 2022, 12, 323-323 dx.doi.org/10.1038/s41598-021-03734-6

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780

Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D

Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)

CANCER CAUSES & CONTROL, 2022, 33, 125-136 dx.doi.org/10.1007/s10552-021-01511-4

Formulari de contacte

Conoce el IDIBGI!

menu